Neonatal alloimmune thrombocytopenia (NAIT) is a critical condition that affects newborns, resulting from an incompatibility between the mother’s and the baby’s platelet antigens. This incompatibility leads to the mother’s immune system attacking the baby’s platelets, causing a significantly reduced platelet count in the newborn. One of the genetic markers associated with an increased risk of NAIT is a variation in the ITGB3 gene. DNA Labs UAE offers a comprehensive genetic test to identify the presence of this specific genetic variation, aiding in the diagnosis and management of NAIT.
Symptoms of ITGB3 Gene Thrombocytopenia Neonatal Alloimmune
Understanding the symptoms of ITGB3 gene thrombocytopenia neonatal alloimmune is crucial for early detection and management. The primary symptom of this condition is a significantly low platelet count in newborns, which may lead to various complications. Some of the common symptoms include:
- Petechiae or small red or purple spots on the skin, resulting from minor bleeds under the skin.
- Purpura or larger areas of bleeding under the skin, which may appear as large purple bruises.
- Bleeding from the nose or gums without any apparent cause.
- Increased bleeding during or after medical procedures, such as circumcision.
- In severe cases, internal bleeding, including intracranial hemorrhage, can occur, posing a significant risk to the newborn’s health and development.
It is important for parents and healthcare providers to be aware of these symptoms, as early detection and intervention can significantly improve outcomes for affected newborns.
ITGB3 Gene Thrombocytopenia Neonatal Alloimmune Genetic Test
DNA Labs UAE provides a specialized genetic test to detect variations in the ITGB3 gene associated with neonatal alloimmune thrombocytopenia. This test is a crucial tool for diagnosing the condition and facilitating early intervention. The test involves a simple blood draw from the parents, which is then analyzed for the presence of the specific ITGB3 gene variation. The process is straightforward and minimally invasive, making it an accessible option for many families.
The cost of the ITGB3 gene thrombocytopenia neonatal alloimmune genetic test at DNA Labs UAE is 4400 AED. While the cost may seem significant, it is a valuable investment in the health and well-being of the newborn, potentially preventing severe complications and ensuring appropriate management of the condition.
For more information about the test and to schedule an appointment, please visit DNA Labs UAE.
Conclusion
Neonatal alloimmune thrombocytopenia is a serious condition that requires prompt diagnosis and management. The ITGB3 gene thrombocytopenia neonatal alloimmune genetic test provided by DNA Labs UAE is an essential tool in the early detection and treatment of this condition. By understanding the symptoms and availing of the genetic testing services offered, parents and healthcare providers can ensure the best possible outcomes for affected newborns. The cost of the test is a small price to pay for the health and well-being of a child.
For more detailed information and to book a test, visit the DNA Labs UAE website and take the first step towards securing your newborn’s health today.
